Søren Rafael Rafaelsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Søren Rafael Rafaelsen has a total of 254 co-authors. Here are the top co-authors by number of shared publications:
- Malene Roland Vils Pedersen
Department of Radiology, University Hospital of Southern Denmark, 7100 Vejle, Denmark
30 shared publications - Anders Jakobsen
Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
22 shared publications Jan Lindebjerg
Danish Colorectal Cancer Center South, Vejle University Hospital, Vejle, Denmark; Institute of Regional Health Research, University of Southern Denmark, Denmark; Department of Pathology, Vejle Hospital, University of Southern Denmark, Vejle, Denmark
13 shared publications- Lars Henrik Jensen
Department of Oncology, University Hospital of Southern Denmark, Vejle Hospital, Vejle, Denmark
13 shared publications - Torben Hansen
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark
12 shared publications - Jan Lindebjerg
Danish Colorectal Cancer Center South, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark
9 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by Elsevier in Radiography
- Vol. 32 (7)
Automated CO2 insufflation and image quality in CT colonography
- 27 August 2026
- Published by Elsevier in Radiography
- Vol. 32 (7)
Open AccessAutomated CO2 insufflation and image quality in CT colonography
- 4 June 2026
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (7) , 601-606
Assessment of intra- and inter-observer variability in T1 relaxation time measurement for rectal cancer
Background: In search of more accurate methods for rectal cancer diagnostics, T1 relaxation time measurement might have potential to become highly clinically relevant. The reproducibility of the methods has only been tested in few studies. Purpose: To investigate the reproducibility of measuring T1 relaxation time in rectal cancer by assessing the intra- and inter-observer variability. Material and Methods: In this inter- and intra-observer study, magnetic resonance imaging (MRI) T1 maps were prospectively collected and analyzed by two observers. All images were obtained on 1.5-T MRI-units. T1 relaxation time was measured by contouring around the tumor border using free hand technique on a single slice. Intra- and inter-observer agreement were evaluated by the intraclass correlation coefficient (ICC) and Bland–Altman plots. Results: A total of 41 MRI scans were included between 1 January and 31 October 2024. The cohort comprised 26 men and 15 women, with a mean age of 70 years (range = 28–92 years). The inter-observer agreement of T1 relaxation time was excellent across two reads with an ICC of 0.93 (95% confidence interval [CI]=0.85–0.97) and 0.91 (95% CI=0.83–0.95). The intra-observer agreement was excellent for both readers with an ICC of 0.94 (95% CI=0.88–0.97) for the less experienced reader and 0.90 (95% CI=0.81–0.95) for the experienced reader. Conclusion: In conclusion, analysis of MRI T1 maps and measuring of T1 relaxation time for evaluation of rectal cancer is has a high ICC. A reliable method is essential in the evaluation of complete response after neoadjuvant treatment.
- 4 June 2026
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (7) , 601-606
Assessment of intra- and inter-observer variability in T1 relaxation time measurement for rectal cancer
Background: In search of more accurate methods for rectal cancer diagnostics, T1 relaxation time measurement might have potential to become highly clinically relevant. The reproducibility of the methods has only been tested in few studies. Purpose: To investigate the reproducibility of measuring T1 relaxation time in rectal cancer by assessing the intra- and inter-observer variability. Material and Methods: In this inter- and intra-observer study, magnetic resonance imaging (MRI) T1 maps were prospectively collected and analyzed by two observers. All images were obtained on 1.5-T MRI-units. T1 relaxation time was measured by contouring around the tumor border using free hand technique on a single slice. Intra- and inter-observer agreement were evaluated by the intraclass correlation coefficient (ICC) and Bland–Altman plots. Results: A total of 41 MRI scans were included between 1 January and 31 October 2024. The cohort comprised 26 men and 15 women, with a mean age of 70 years (range = 28–92 years). The inter-observer agreement of T1 relaxation time was excellent across two reads with an ICC of 0.93 (95% confidence interval [CI]=0.85–0.97) and 0.91 (95% CI=0.83–0.95). The intra-observer agreement was excellent for both readers with an ICC of 0.94 (95% CI=0.88–0.97) for the less experienced reader and 0.90 (95% CI=0.81–0.95) for the experienced reader. Conclusion: In conclusion, analysis of MRI T1 maps and measuring of T1 relaxation time for evaluation of rectal cancer is has a high ICC. A reliable method is essential in the evaluation of complete response after neoadjuvant treatment.
- Open Access
- 24 April 2026
- Published by Elsevier in SSRN Electronic Journal
Quantitative MRI T1 Relaxation Time as a Biomarker of Complete Response in Rectal Cancer Six Weeks after Neoadjuvant Therapy: A Prospective Study
Purpose The purpose of the study was to investigate the performance of quantitative magnetic resonance imaging (MRI) T1 relaxation time for early identification of complete response (CR) following neoadjuvant therapy in patients with rectal cancer. Materials and methods We prospectively included patients with rectal cancer selected for neoadjuvant therapy. We used a 1.5 T MRI unit. T1 relaxation time was measured at baseline and six weeks after completion of neoadjuvant therapy. Endpoints were pathological CR confirmed by the surgical specimen in operated cases or clinical CR determined by three-month follow-up MRI combined with endoscopy in non-operated (watch-and-wait) cases. Data were analysed using paired t-test. Results We included 44 patients (27 male, mean age 63 years (36 – 83)). At baseline, patients with and without CR had similar T1 relaxation times with means of 1370 ms (95% CI 1294 – 1446 ms) for the CR-group and 1419 ms (95% CI: 1365 – 1473 ms) for the incomplete response (iCR)-group, p=0.22. At six weeks follow-up, the CR-group decreased to 632 ms (95% CI 542 – 723) and the iCR-group remained at 1301 ms (95% CI 1165 – 1437). We found a cut-off value of 1088 ms with a sensitivity at 88.5%, specificity at 100% and an area under the curve of 0.94 (95% CI: 0.82 – 1.00). Positive predictive value for CR was 100% and the negative predictive value 85.7%. Conclusion Quantitative MRI T1 relaxation time shows a strong performance for identification of CR six weeks after neoadjuvant therapy in rectal cancer and may support response-adapted treatment strategies.
- 24 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessQuantitative MRI T1 Relaxation Time as a Biomarker of Complete Response in Rectal Cancer Six Weeks after Neoadjuvant Therapy: A Prospective Study
Purpose The purpose of the study was to investigate the performance of quantitative magnetic resonance imaging (MRI) T1 relaxation time for early identification of complete response (CR) following neoadjuvant therapy in patients with rectal cancer. Materials and methods We prospectively included patients with rectal cancer selected for neoadjuvant therapy. We used a 1.5 T MRI unit. T1 relaxation time was measured at baseline and six weeks after completion of neoadjuvant therapy. Endpoints were pathological CR confirmed by the surgical specimen in operated cases or clinical CR determined by three-month follow-up MRI combined with endoscopy in non-operated (watch-and-wait) cases. Data were analysed using paired t-test. Results We included 44 patients (27 male, mean age 63 years (36 – 83)). At baseline, patients with and without CR had similar T1 relaxation times with means of 1370 ms (95% CI 1294 – 1446 ms) for the CR-group and 1419 ms (95% CI: 1365 – 1473 ms) for the incomplete response (iCR)-group, p=0.22. At six weeks follow-up, the CR-group decreased to 632 ms (95% CI 542 – 723) and the iCR-group remained at 1301 ms (95% CI 1165 – 1437). We found a cut-off value of 1088 ms with a sensitivity at 88.5%, specificity at 100% and an area under the curve of 0.94 (95% CI: 0.82 – 1.00). Positive predictive value for CR was 100% and the negative predictive value 85.7%. Conclusion Quantitative MRI T1 relaxation time shows a strong performance for identification of CR six weeks after neoadjuvant therapy in rectal cancer and may support response-adapted treatment strategies.
- 9 March 2026
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (5) , 418-425
Inter-observer variability for detection of suspected ileocolonic Crohn’s disease with magnetic resonance enterography
Background: Magnetic resonance enterography (MRE) can visualize Crohn's disease (CD) and its complications. Purpose: To determine the inter-observer agreement for the detection of ileocolonic CD. Material and Methods: This post-hoc analysis included MRE scans from 48 patients selected from a prospective, blinded multicenter study of patients with suspected CD. Based on ileocolonoscopy in the main study, CD was diagnosed in 39 (81%) patients, with colonic involvement in 36 (69%). Two senior radiologists and two junior doctors undergoing specialist training, blinded to clinical data assessed the image quality, CD presence, and disease severity. Results: The inter-observer agreement for CD detection varied by location: terminal ileum (κ = 0.77, 95% confidence interval [CI] = 0.63–0.89), colon (κ = 0.59, 95% CI = 0.42–0.74), and ileocolon (κ = 0.65, 95% CI = 0.49–0.80). Agreement was higher among senior radiologists than juniors: terminal ileum (κ = 0.83 vs. 0.73; P = 0.60) and colon (κ = 0.73 vs. 0.41; P = 0.11), though differences were not statistically significant. The inter-observer agreement for disease severity was poor to moderate with intraclass correlation coefficients (ICCs) of 0.51 (95% CI = 0.35–0.67) for the MaRIA and 0.46 (95% CI = 0.29–0.62) for the simplified MaRIA. Senior radiologists showed higher consistency, with moderate to good agreement: ICC of 0.69 for the MaRIA, 0.70 for the simplified MaRIA, and 0.80 for bowel wall thickness. Conclusion: In early CD, MRE demonstrated moderate to substantial inter-observer agreement for ileocolonic evaluation. Limitations in colonic assessment likely reflect early disease detection rather than observer variability, highlighting the need for a complementary assessment.
- 9 March 2026
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (5) , 418-425
Inter-observer variability for detection of suspected ileocolonic Crohn’s disease with magnetic resonance enterography
Background: Magnetic resonance enterography (MRE) can visualize Crohn's disease (CD) and its complications. Purpose: To determine the inter-observer agreement for the detection of ileocolonic CD. Material and Methods: This post-hoc analysis included MRE scans from 48 patients selected from a prospective, blinded multicenter study of patients with suspected CD. Based on ileocolonoscopy in the main study, CD was diagnosed in 39 (81%) patients, with colonic involvement in 36 (69%). Two senior radiologists and two junior doctors undergoing specialist training, blinded to clinical data assessed the image quality, CD presence, and disease severity. Results: The inter-observer agreement for CD detection varied by location: terminal ileum (κ = 0.77, 95% confidence interval [CI] = 0.63–0.89), colon (κ = 0.59, 95% CI = 0.42–0.74), and ileocolon (κ = 0.65, 95% CI = 0.49–0.80). Agreement was higher among senior radiologists than juniors: terminal ileum (κ = 0.83 vs. 0.73; P = 0.60) and colon (κ = 0.73 vs. 0.41; P = 0.11), though differences were not statistically significant. The inter-observer agreement for disease severity was poor to moderate with intraclass correlation coefficients (ICCs) of 0.51 (95% CI = 0.35–0.67) for the MaRIA and 0.46 (95% CI = 0.29–0.62) for the simplified MaRIA. Senior radiologists showed higher consistency, with moderate to good agreement: ICC of 0.69 for the MaRIA, 0.70 for the simplified MaRIA, and 0.80 for bowel wall thickness. Conclusion: In early CD, MRE demonstrated moderate to substantial inter-observer agreement for ileocolonic evaluation. Limitations in colonic assessment likely reflect early disease detection rather than observer variability, highlighting the need for a complementary assessment.
- 15 October 2025
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (1) , 50-59
Diagnostic accuracy of simple magnetic resonance imaging markers for detection of treatment response compared to complex disease activity scores in patients with active Crohn's disease
Background: Magnetic resonance imaging (MRI) scores have been validated for monitoring Crohn’s disease (CD) but are not widely used in clinical practice. Purpose: To evaluate treatment response in patients with active CD using simple imaging markers compared to complex multifactorial scores. Material and Methods: This was a post-hoc analysis of MRI-enterocolonographies performed in a prospective, blinded, multicenter study. Patients with endoscopically active CD completed ileocolonoscopy and MRI with intravenous contrast and diffusion-weighted sequences before and after medical treatment. Response was defined as ≥50% reduction of the Simple Endoscopic Score for Crohn’s Disease. Changes in bowel wall thickness (BWT) and apparent diffusion coefficient (ADC) were compared to the magnetic resonance index of activity (MaRIA), simplified MaRIA, and Clermont score. Results: A total of 42 patients entered the analysis, and endoscopic response was achieved in 19 (45.2%). All activity scores improved in patients with endoscopic response compared to non-responders ( P P = 0.1). The per-segment response was more accurately evaluated with BWT compared to the segmental MaRIA score (AUC=0.82 and 0.67, respectively; P = 0.05). A 17% decrease in BWT resulted in an optimal sensitivity and specificity of 78.9% (95% CI=54.4–93.9) and 85.2% (95% CI=66.3–95.8), respectively. Conclusion: BWT is not inferior to MaRIA when determining treatment response in CD. This measure is simple to perform and does not require intravenous contrast.
- 15 October 2025
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (1) , 50-59
Diagnostic accuracy of simple magnetic resonance imaging markers for detection of treatment response compared to complex disease activity scores in patients with active Crohn's disease
Background: Magnetic resonance imaging (MRI) scores have been validated for monitoring Crohn’s disease (CD) but are not widely used in clinical practice. Purpose: To evaluate treatment response in patients with active CD using simple imaging markers compared to complex multifactorial scores. Material and Methods: This was a post-hoc analysis of MRI-enterocolonographies performed in a prospective, blinded, multicenter study. Patients with endoscopically active CD completed ileocolonoscopy and MRI with intravenous contrast and diffusion-weighted sequences before and after medical treatment. Response was defined as ≥50% reduction of the Simple Endoscopic Score for Crohn’s Disease. Changes in bowel wall thickness (BWT) and apparent diffusion coefficient (ADC) were compared to the magnetic resonance index of activity (MaRIA), simplified MaRIA, and Clermont score. Results: A total of 42 patients entered the analysis, and endoscopic response was achieved in 19 (45.2%). All activity scores improved in patients with endoscopic response compared to non-responders ( P P = 0.1). The per-segment response was more accurately evaluated with BWT compared to the segmental MaRIA score (AUC=0.82 and 0.67, respectively; P = 0.05). A 17% decrease in BWT resulted in an optimal sensitivity and specificity of 78.9% (95% CI=54.4–93.9) and 85.2% (95% CI=66.3–95.8), respectively. Conclusion: BWT is not inferior to MaRIA when determining treatment response in CD. This measure is simple to perform and does not require intravenous contrast.
- Open Access
- 30 July 2025
- Published by SAGE Publications in Acta Radiologica Open
- Vol. 14 (7)
MRI T1 relaxation time for evaluating early complete response to neoadjuvant treatment in rectal cancer: measurement at six weeks – a protocol article
Background: Management of rectal cancer requires accurate staging and treatment. Neoadjuvant chemoradiotherapy offers tumour size reduction and mitigation of the risk of local relapse. Patients with complete response to neoadjuvant treatment can be enclosed in watchful waiting (WW). Recent studies have explored magnetic resonance imaging (MRI) T1 relaxation time (T1RT) as a predictive biomarker for treatment response in rectal cancer. Preliminary findings indicate that lower T1RT correlates with pathologic complete response. However, inclusion of patients in WW remains unexplored. Purpose: This prospective study aims to investigate T1RT 6 weeks after neoadjuvant treatment and the ability to determine complete response. Material and methods: MRI scans are conducted on a 1.5 T MRI-unit. T1RT is measured at time of diagnosis and 6 weeks after neoadjuvant treatment. Experienced radiologists analyse T1RT using specialised software. Treatment decisions are made in multidisciplinary team conferences based on tumour staging. Endpoints include tumour visibility on MRI and endoscopy, along with histopathological analysis of surgical specimens. Statistical methods include t test and receiver operating characteristic curves. Sample size calculations showed we must enrol 76 participants to achieve a statistical power of 80% with an α = 0.05. Results: Data analysis begins in winter 2025. Results are planned to be submitted in spring 2026. Conclusion: The implications of this study extend to the potential refinement of treatment strategies, offering patients the prospect of improved outcomes and the potential avoidance of surgery-associated risks. We expect to find a lower relaxation time in fibrotic tissue compared to non-responsive cancerous tissue after 6 weeks.
- 30 July 2025
- Published by SAGE Publications in Acta Radiologica Open
- Vol. 14 (7)
Open AccessMRI T1 relaxation time for evaluating early complete response to neoadjuvant treatment in rectal cancer: measurement at six weeks – a protocol article
Background: Management of rectal cancer requires accurate staging and treatment. Neoadjuvant chemoradiotherapy offers tumour size reduction and mitigation of the risk of local relapse. Patients with complete response to neoadjuvant treatment can be enclosed in watchful waiting (WW). Recent studies have explored magnetic resonance imaging (MRI) T1 relaxation time (T1RT) as a predictive biomarker for treatment response in rectal cancer. Preliminary findings indicate that lower T1RT correlates with pathologic complete response. However, inclusion of patients in WW remains unexplored. Purpose: This prospective study aims to investigate T1RT 6 weeks after neoadjuvant treatment and the ability to determine complete response. Material and methods: MRI scans are conducted on a 1.5 T MRI-unit. T1RT is measured at time of diagnosis and 6 weeks after neoadjuvant treatment. Experienced radiologists analyse T1RT using specialised software. Treatment decisions are made in multidisciplinary team conferences based on tumour staging. Endpoints include tumour visibility on MRI and endoscopy, along with histopathological analysis of surgical specimens. Statistical methods include t test and receiver operating characteristic curves. Sample size calculations showed we must enrol 76 participants to achieve a statistical power of 80% with an α = 0.05. Results: Data analysis begins in winter 2025. Results are planned to be submitted in spring 2026. Conclusion: The implications of this study extend to the potential refinement of treatment strategies, offering patients the prospect of improved outcomes and the potential avoidance of surgery-associated risks. We expect to find a lower relaxation time in fibrotic tissue compared to non-responsive cancerous tissue after 6 weeks.
- Open Access
An Insight into Testicular Macrocalcification—A Retrospective Study of 42 Cases on a Rare Sonographic Finding
A single testicular microlithiasis is a common finding during sonography, while macrocalcification is a rare and incidental finding. The literature on macrocalcification is limited. Typically, testicular calcifications, whether microscopic or macroscopic, are benign but they can have a clinical significance. This multicenter study aimed to investigate the symptoms and prevalence of testicular cancer in patients with macrocalcification. Methods: Testicular ultrasound examination reports from four hospitals’ PACS database, covering the period 2014–2023, were screened for diagnoses of macrocalcification. Inclusion criteria required that the radiology report described macrocalcification supported by ultrasound images. Results: Macrocalcifications were identified in 42 male patients, with a mean age of 45 years. Sixteen macrocalcifications were in the right testicle, twenty in the left, and six were bilateral. Microlithiasis were found in 22 patients (52.4%), with 11 (26.2%) bilateral, 3 (7.1%) left-sided, and 8 (19.1%) right-sided. Testicular tumors were found in six patients. Conclusion: Testicular macrocalcification exhibited large visual variation and diverse clinical history. However, we found a low number of patients with testicular macrocalcification and testicular tumors, indicating that macrocalcifications have a benign nature, and that macrocalcification alone should not be a primary concern for malignancy, but this needs to be confirmed in further studies.
Open AccessAn Insight into Testicular Macrocalcification—A Retrospective Study of 42 Cases on a Rare Sonographic Finding
A single testicular microlithiasis is a common finding during sonography, while macrocalcification is a rare and incidental finding. The literature on macrocalcification is limited. Typically, testicular calcifications, whether microscopic or macroscopic, are benign but they can have a clinical significance. This multicenter study aimed to investigate the symptoms and prevalence of testicular cancer in patients with macrocalcification. Methods: Testicular ultrasound examination reports from four hospitals’ PACS database, covering the period 2014–2023, were screened for diagnoses of macrocalcification. Inclusion criteria required that the radiology report described macrocalcification supported by ultrasound images. Results: Macrocalcifications were identified in 42 male patients, with a mean age of 45 years. Sixteen macrocalcifications were in the right testicle, twenty in the left, and six were bilateral. Microlithiasis were found in 22 patients (52.4%), with 11 (26.2%) bilateral, 3 (7.1%) left-sided, and 8 (19.1%) right-sided. Testicular tumors were found in six patients. Conclusion: Testicular macrocalcification exhibited large visual variation and diverse clinical history. However, we found a low number of patients with testicular macrocalcification and testicular tumors, indicating that macrocalcifications have a benign nature, and that macrocalcification alone should not be a primary concern for malignancy, but this needs to be confirmed in further studies.
- 4 November 2024
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 31 (7) , 1891-1901
Assessment of Treatment Response in Known Crohn’s Disease—A Prospective Blinded Study Comparing the Diagnostic Accuracy of Intestinal Ultrasound, Magnetic Resonance Enterocolonography, Panenteric Capsule Endoscopy, and Fecal Calprotectin
Background: Minimally invasive modalities may replace ileocolonoscopy (IC) in the follow-up of Crohn’s disease (CD). The aim of this study was to evaluate intestinal ultrasound (IUS), magnetic resonance enterocolonography (MREC), panenteric capsule endoscopy (PCE), and fecal calprotectin (FC) for determining response to medical treatment in patients with ileocolonic CD. Methods: This prospective, blinded, multicenter study included patients with endoscopically active CD. Patients were scheduled for IC, MREC, IUS, PCE, and FC before and 12 weeks after treatment with corticosteroids or biological therapy. A ≥50% reduction of the Simple Endoscopic Score for Crohn’s Disease (SES-CD) with IC defined treatment response. Results: Fifty patients completed the pre- and posttreatment evaluation with IC, and endoscopic response was achieved in 25 (50.0%). PCE was omitted in 12 (24.0%) patients because of stricturing CD. All activity scores decreased in patients achieving endoscopic response: The Simple Ultrasound Score for Crohn’s Disease 2.2 vs 6.1 (P < .001), Magnetic Resonance Index of Activity 29.0 vs 37.1 (P = .05), SES-CD with PCE 3.1 vs 12.8 (P < .001), and FC 115.3 vs 1339.9 mg/kg (P < .001). The sensitivity and specificity of IUS, MREC, PCE, and FC were 80.0% (95% CI, 56.3-94.3)/77.8% (95% CI, 52.4-93.6), 65.2% (95% CI, 42.7-83.6)/87.0% (95% CI, 66.4-97.2), 87.5% (95% CI, 61.7-98.4)/86.7% (95% CI, 59.5-98.3), and 90.0% (95% CI, 68.3-98.8)/86.4% (95% CI, 65.1-97.1), respectively. Conclusions: IUS and FC are equally effective for determining treatment response in patients with active CD. PCE is limited by the occurrence of strictures in this group of patients.
- 4 November 2024
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 31 (7) , 1891-1901
Assessment of Treatment Response in Known Crohn’s Disease—A Prospective Blinded Study Comparing the Diagnostic Accuracy of Intestinal Ultrasound, Magnetic Resonance Enterocolonography, Panenteric Capsule Endoscopy, and Fecal Calprotectin
Background: Minimally invasive modalities may replace ileocolonoscopy (IC) in the follow-up of Crohn’s disease (CD). The aim of this study was to evaluate intestinal ultrasound (IUS), magnetic resonance enterocolonography (MREC), panenteric capsule endoscopy (PCE), and fecal calprotectin (FC) for determining response to medical treatment in patients with ileocolonic CD. Methods: This prospective, blinded, multicenter study included patients with endoscopically active CD. Patients were scheduled for IC, MREC, IUS, PCE, and FC before and 12 weeks after treatment with corticosteroids or biological therapy. A ≥50% reduction of the Simple Endoscopic Score for Crohn’s Disease (SES-CD) with IC defined treatment response. Results: Fifty patients completed the pre- and posttreatment evaluation with IC, and endoscopic response was achieved in 25 (50.0%). PCE was omitted in 12 (24.0%) patients because of stricturing CD. All activity scores decreased in patients achieving endoscopic response: The Simple Ultrasound Score for Crohn’s Disease 2.2 vs 6.1 (P < .001), Magnetic Resonance Index of Activity 29.0 vs 37.1 (P = .05), SES-CD with PCE 3.1 vs 12.8 (P < .001), and FC 115.3 vs 1339.9 mg/kg (P < .001). The sensitivity and specificity of IUS, MREC, PCE, and FC were 80.0% (95% CI, 56.3-94.3)/77.8% (95% CI, 52.4-93.6), 65.2% (95% CI, 42.7-83.6)/87.0% (95% CI, 66.4-97.2), 87.5% (95% CI, 61.7-98.4)/86.7% (95% CI, 59.5-98.3), and 90.0% (95% CI, 68.3-98.8)/86.4% (95% CI, 65.1-97.1), respectively. Conclusions: IUS and FC are equally effective for determining treatment response in patients with active CD. PCE is limited by the occurrence of strictures in this group of patients.
- 23 September 2024
- Published by SAGE Publications in Acta Radiologica
- Vol. 65 (11) , 1305-1306
Implementation of template-based reporting for rectal cancer
- 23 September 2024
- Published by SAGE Publications in Acta Radiologica
- Vol. 65 (11) , 1305-1306
Implementation of template-based reporting for rectal cancer
- 21 May 2024
- Published by SAGE Publications in Acta Radiologica
- Vol. 65 (8) , 877-878
Enhancement of image quality in rectal cancer imaging through MRI supplemented with rectal micro-enema
- 21 May 2024
- Published by SAGE Publications in Acta Radiologica
- Vol. 65 (8) , 877-878
Enhancement of image quality in rectal cancer imaging through MRI supplemented with rectal micro-enema